Tesamorelin is a growth-hormone-releasing analog that can increase IGF-1 levels in both men and women by an average of 181 micrograms/liter. This growth hormone can bind and stimulate the GHRH receptors that have a similar potency with GHRH.
This growth hormone also hosts many benefits which include:
Nootropic effects
Reducing triglycerides
Tesamorelin has shown to decrease carotid intima-media thickness (cIMT), visceral adipose tissue (VAT) and c-reactive protein (CRP.) Although, this growth hormone has not been linked to significantly affect other pituitary hormones and other respective mechanisms of the body. 
Besides, Tesamorelin can also improve cognitive function for people with old age, and patients who suffer increase risk in Alzheimer’s disease due to mild cognitive impairment. 
 
Properties
Chemical Formula: C221H366N72067S
Molecular Mass: 5136
Synonyms: Egrifta Tesamorelin, UNII-MQG94M5EEO, MQG94M5EEO, 804475-66-9
Molar Mass: 5136.86
CAS Number: 218949-48-5
PubChem: 16137828
 
Description 
Tesamorelin is a synthesized GHRH peptide derivative and is clinically used for HIV-associated lipodystrophy, a condition characterized by a fast-acting accumulation of fat in the abdominal area.
Tesamorelin is being researched for its ability to stimulate the pituitary gland into producing more growth hormones, with its demonstrated ability to reduce visceral adipose tissue or deep abdominal fat associated with a number of concerning health risks.